Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue | 8.99bn | 8.76bn | 8.72bn | 8.32bn |
| Cost of revenue | 7.51bn | 7.25bn | 7.27bn | 7.00bn |
| Research and development | 166m | 169m | 176m | 241m |
| Selling, general and administrative | 576m | 647m | 535m | 612m |
| Operating income | −213m | −339m | −399m | −686m |
| Interest expense | — | — | — | 73m |
| Pre-tax income | −139m | −267m | −305m | −732m |
| Income tax | 689,000 | 1m | 195,000 | −471,000 |
| Net income | −140m | −268m | −304m | −736m |
| Earnings per share | −0.02 | −0.05 | −0.63 | −0.94 |
| Earnings per share, diluted | −0.02 | −0.05 | −0.63 | −0.94 |
| Weighted average shares | 5.69bn | 5.74bn | 1.53bn | 1.33bn |
| Weighted average shares, diluted | 5.69bn | 5.74bn | 1.53bn | 1.33bn |
| Metric | Aug 19, 2026 | Aug 18, 2026 | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | — | — | 1.03bn | 1.42bn | 1.09bn | 2.01bn | 1.13bn |
| Short-term investments | — | — | 825m | 544m | 874m | — | — |
| Receivables | — | — | 3.26bn | 3.09bn | 3.64bn | — | — |
| Inventory | — | — | 670m | 625m | 669m | — | — |
| Current assets | — | — | 6.14bn | 6.19bn | 6.95bn | — | — |
| Property, plant and equipment | — | — | 186m | 184m | 145m | — | — |
| Goodwill | — | — | 31m | 31m | 31m | — | — |
| Total assets | — | — | 6.53bn | 6.61bn | 7.39bn | — | — |
| Current liabilities | — | — | 3.43bn | 3.34bn | 4.03bn | — | — |
| Short-term debt | — | — | 2m | 997,000 | 585m | — | — |
| Long-term debt | — | — | 43m | 39m | — | — | — |
| Total liabilities | — | — | 3.59bn | 3.51bn | 4.18bn | — | — |
| Equity | — | — | 2.94bn | 3.10bn | 3.21bn | −4.07bn | −2.77bn |
| Shares outstanding | — | — | 5.56bn | 5.66bn | 5.62bn | — | — |
| Shares issued | — | — | 5.68bn | 5.66bn | 5.62bn | — | — |
| Metric | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
|---|---|---|---|---|
| Operating cash flow | 9m | 229m | −568m | −504m |
| Depreciation and amortisation | 48m | 55m | 73m | 76m |
| Share-based compensation | 54m | 109m | 17m | 32m |
| Capital expenditure | 53m | 79m | 50m | 37m |
| Investing cash flow | −324m | 276m | −908m | −37m |
| Share buybacks | 41m | 41m | — | — |
| Financing cash flow | −104m | −254m | 716m | 1.30bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)